TipRanks
Advertisement
Advertisement

DE:D6M Stock Latest News

Genedrive’s Neonatal Hearing-Loss Test Gains Wider NHS Adoption Ahead of NICE Ruling
Company AnnouncementsGenedrive’s Neonatal Hearing-Loss Test Gains Wider NHS Adoption Ahead of NICE Ruling
27d ago
Genedrive to Host ShareSoc Investor Webinar as Precision Diagnostics Roll Out in NHS
PremiumCompany Announcements
Genedrive to Host ShareSoc Investor Webinar as Precision Diagnostics Roll Out in NHS
1M ago
Genedrive Executives Increase Shareholdings as Precision Diagnostics Push Advances
PremiumCompany Announcements
Genedrive Executives Increase Shareholdings as Precision Diagnostics Push Advances
1M ago
Genedrive strengthens board as it targets next phase of pharmacogenetic growth
PremiumCompany Announcements
Genedrive strengthens board as it targets next phase of pharmacogenetic growth
2M ago
Genedrive to Brief Investors on Commercial Progress in Upcoming ShareSoc Webinar
PremiumCompany Announcements
Genedrive to Brief Investors on Commercial Progress in Upcoming ShareSoc Webinar
2M ago
Genedrive completes PALOH-UK recruitment as MT-RNR1 test advances in NICE process
PremiumCompany AnnouncementsGenedrive completes PALOH-UK recruitment as MT-RNR1 test advances in NICE process
2M ago
Genedrive expands MT-RNR1 neonatal hearing-loss test to leading Dutch hospital
Premium
Company Announcements
Genedrive expands MT-RNR1 neonatal hearing-loss test to leading Dutch hospital
2M ago
Genedrive buoyed as new UK guideline backs its MT-RNR1 point-of-care test
Premium
Company Announcements
Genedrive buoyed as new UK guideline backs its MT-RNR1 point-of-care test
2M ago
Genedrive strengthens board with Graham Cole CBE as new chair
PremiumCompany Announcements
Genedrive strengthens board with Graham Cole CBE as new chair
3M ago
Genedrive lifts revenues as NHS and international uptake of rapid genetic tests builds
PremiumCompany Announcements
Genedrive lifts revenues as NHS and international uptake of rapid genetic tests builds
3M ago
Genedrive Wins Ministerial Backing as NHS Expands Rapid Pharmacogenetic Testing
PremiumCompany Announcements
Genedrive Wins Ministerial Backing as NHS Expands Rapid Pharmacogenetic Testing
3M ago
Genedrive launches board shake-up as chairman Ian Gilham steps down
PremiumCompany Announcements
Genedrive launches board shake-up as chairman Ian Gilham steps down
3M ago
Genedrive expands CYP2C19 diagnostics with Thermo Fisher lab collaboration
PremiumCompany AnnouncementsGenedrive expands CYP2C19 diagnostics with Thermo Fisher lab collaboration
3M ago
Genedrive’s MT-RNR1 Test Adopted as Routine Neonatal Service at Manchester NHS Trust
Premium
Company Announcements
Genedrive’s MT-RNR1 Test Adopted as Routine Neonatal Service at Manchester NHS Trust
4M ago
Genedrive Secures £0.76m R&D Tax Credit to Support Expansion of Point-of-Care Genetics
Premium
Company Announcements
Genedrive Secures £0.76m R&D Tax Credit to Support Expansion of Point-of-Care Genetics
4M ago
Genedrive Reports No Change in Share Option Scheme Balances in Latest Block Listing Return
PremiumCompany Announcements
Genedrive Reports No Change in Share Option Scheme Balances in Latest Block Listing Return
4M ago
Genedrive Reports No Share Issuance in Latest Block Listing Return
PremiumCompany Announcements
Genedrive Reports No Share Issuance in Latest Block Listing Return
4M ago
Genedrive reshapes board as major shareholder joins and long-serving chairman prepares exit
PremiumCompany Announcements
Genedrive reshapes board as major shareholder joins and long-serving chairman prepares exit
4M ago
Genedrive Test Adopted as Routine Neonatal Service at Sussex NHS Trust
PremiumCompany Announcements
Genedrive Test Adopted as Routine Neonatal Service at Sussex NHS Trust
5M ago
Genedrive Positioned for NHS Tender as Rapid MT-RNR1 Test Expands Across UK NICUs
PremiumCompany AnnouncementsGenedrive Positioned for NHS Tender as Rapid MT-RNR1 Test Expands Across UK NICUs
6M ago
Genedrive Enhances Investor Hub to Deepen Shareholder Engagement
Premium
Company Announcements
Genedrive Enhances Investor Hub to Deepen Shareholder Engagement
6M ago
Genedrive Secures Charity-Backed Rollout of Stroke Test at Bristol’s Southmead Hospital
Premium
Company Announcements
Genedrive Secures Charity-Backed Rollout of Stroke Test at Bristol’s Southmead Hospital
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >